DEO compared with GMAB: revenue, margins and what each company keeps, and the suppliers and customers both name

DEODiageo PLC

Mkt capRevenueRevenue

GMABGenmab A/S

Mkt capRevenueRevenue

Compare

DEODiageo PLC

GMABGenmab A/S

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

DEODiageo PLC

93.45▲+2.32%· post 93.39

Mkt cap$56.8B

GMABGenmab A/S

57.03▲+0.96%· post 57.15

ClosedOct 30 '26

Mkt cap$36.7B

Compare

ClosedOct 30 '26

DEODiageo PLC

GMABGenmab A/S

93.45▲+2.32%post 93.39

Price

57.03▲+0.96%post 57.15

$56.8B

Mkt cap

$36.7B

DEO93.45▲+2.32%vsGMAB57.03▲+0.96%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

DEO, solidGMAB, dashed

Supply-chain overlap

Revenue flow

DEO: latest quarter not drawable. GMAB: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only DEO 1

JJacobs Solutionssupplier

Shared 0

No shared counterparties.

Only GMAB 1

COAGHemab Therapeuticscustomer

Role chip = supplier or customerSource: SEC EDGAR